LINE-1 methylation in leukocyte DNA, interaction with phosphatidylethanolamine N-methyltransferase variants and bladder cancer risk

[1]  R. Gangnon,et al.  Telomere Length and Pancreatic Cancer: A Case–Control Study , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[2]  Peter A. Jones Functions of DNA methylation: islands, start sites, gene bodies and beyond , 2012, Nature Reviews Genetics.

[3]  U. Capitanio,et al.  Serum Sex Steroids Depict a Nonlinear U-Shaped Association with High-Risk Prostate Cancer at Radical Prostatectomy , 2012, Clinical Cancer Research.

[4]  D. Silverman,et al.  Correlation of LINE-1 Methylation Levels in Patient-Matched Buffy Coat, Serum, Buccal Cell, and Bladder Tumor Tissue DNA Samples , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[5]  Jeongseon Kim,et al.  Global DNA Hypomethylation in Peripheral Blood Leukocytes as a Biomarker for Cancer Risk: A Meta-Analysis , 2012, PloS one.

[6]  C. Marsit,et al.  LINE‐1 hypomethylation is associated with bladder cancer risk among nonsmoking Chinese , 2012, International journal of cancer.

[7]  N. Malats,et al.  Pancreatic cancer risk and levels of trace elements , 2011, Gut.

[8]  Z. Bhujwalla,et al.  Choline metabolism in malignant transformation , 2011, Nature Reviews Cancer.

[9]  N. Rothman,et al.  LINE-1 Methylation Levels in Leukocyte DNA and Risk of Renal Cell Cancer , 2011, PloS one.

[10]  Jian Gu,et al.  A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3. , 2011, Human molecular genetics.

[11]  F. Clavel-Chapelon,et al.  A U-shaped relationship between plasma folate and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. , 2011, European journal of cancer.

[12]  R. Santella,et al.  Global methylation profiles in DNA from different blood cell types , 2011, Epigenetics.

[13]  M. Thun,et al.  A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC 14 A 1 , a urea transporter gene on chromosome 18 q 12 . 3 , 2011 .

[14]  P. Ueland Choline and betaine in health and disease , 2011, Journal of Inherited Metabolic Disease.

[15]  William Wheeler,et al.  A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci , 2010, Nature Genetics.

[16]  C. Font,et al.  Tobacco-related tumours of the lung, bladder and larynx: changes in Spain. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  Peter A. Jones,et al.  Hypomethylation of a LINE-1 Promoter Activates an Alternate Transcript of the MET Oncogene in Bladders with Cancer , 2010, PLoS genetics.

[18]  V. Zoumpourlis,et al.  Environmental factors and genetic susceptibility promote urinary bladder cancer. , 2010, Toxicology letters.

[19]  Rondi A. Butler,et al.  Implications of LINE1 Methylation for Bladder Cancer Risk in Women , 2010, Clinical Cancer Research.

[20]  P. Laird Principles and challenges of genome-wide DNA methylation analysis , 2010, Nature Reviews Genetics.

[21]  Peter A. Jones,et al.  Epigenetics in cancer. , 2010, Carcinogenesis.

[22]  H. Byun,et al.  Changes in DNA methylation of tandem DNA repeats are different from interspersed repeats in cancer , 2009, International journal of cancer.

[23]  S. Wallenstein,et al.  Gene expression profiles of the one-carbon metabolism pathway. , 2009, Journal of genetics and genomics = Yi chuan xue bao.

[24]  A. Mutirangura,et al.  LINE-1 methylation patterns of different loci in normal and cancerous cells , 2008, Nucleic acids research.

[25]  A. Neugut,et al.  Choline metabolism and risk of breast cancer in a population‐based study , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  Debra Silverman,et al.  Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study. , 2008, The Lancet. Oncology.

[27]  W. Schulz,et al.  Chromosomal instability in bladder cancer , 2008, Archives of Toxicology.

[28]  D. Parkin,et al.  The global burden of urinary bladder cancer , 2008, Scandinavian journal of urology and nephrology. Supplementum.

[29]  N. Malats,et al.  Screening for bladder cancer: a perspective , 2008, World Journal of Urology.

[30]  D. Vance,et al.  Hepatic Phosphatidylethanolamine N-Methyltransferase, Unexpected Roles in Animal Biochemistry and Physiology* , 2007, Journal of Biological Chemistry.

[31]  Ivo G Gut,et al.  DNA methylation analysis by pyrosequencing , 2007, Nature Protocols.

[32]  R. Sinha,et al.  Food, nutrient and heterocyclic amine intake and the risk of bladder cancer. , 2007, European journal of cancer.

[33]  N. Malats,et al.  Polymorphisms in one‐carbon metabolism and trans‐sulfuration pathway genes and susceptibility to bladder cancer , 2007, International journal of cancer.

[34]  N. Malats,et al.  Epidemiology of urinary bladder cancer: from tumor development to patient’s death , 2007, World Journal of Urology.

[35]  J. Issa,et al.  LINE-1 Hypomethylation in Cancer Is Highly Variable and Inversely Correlated with Microsatellite Instability , 2007, PloS one.

[36]  Patrick Royston,et al.  Multivariable Modeling with Cubic Regression Splines: A Principled Approach , 2007 .

[37]  Nilanjan Chatterjee,et al.  Large-Scale Evaluation of Candidate Genes Identifies Associations between VEGF Polymorphisms and Bladder Cancer Risk , 2007, PLoS genetics.

[38]  N. Malats,et al.  PIK3CA mutations are an early genetic alteration associated with FGFR3 mutations in superficial papillary bladder tumors. , 2006, Cancer research.

[39]  Núria Malats,et al.  Smoking and Bladder Cancer in Spain: Effects of Tobacco Type, Timing, Environmental Tobacco Smoke, and Gender , 2006, Cancer Epidemiology Biomarkers & Prevention.

[40]  司履生 Cancer epigenetics , 2006 .

[41]  Xue-Ru Wu Urothelial tumorigenesis: a tale of divergent pathways , 2005, Nature Reviews Cancer.

[42]  N. Malats,et al.  NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses , 2005, The Lancet.

[43]  Trygve O Tollefsbol,et al.  The impact of metabolism on DNA methylation. , 2005, Human molecular genetics.

[44]  M. Kogevinas,et al.  NAT 2 slow acetylation , GSTM 1 null genotype , and risk of bladder cancer : results from the Spanish Bladder Cancer Study and meta-analyses , 2005 .

[45]  P. Laird Cancer epigenetics. , 2005, Human molecular genetics.

[46]  B. Jackson,et al.  Trophic and maternal transfer of selenium in brown house snakes (Lamprophis fuliginosus). , 2004, Ecotoxicology and environmental safety.

[47]  J. Issa,et al.  A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. , 2004, Nucleic acids research.

[48]  Pär Stattin,et al.  Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case‐control study in the Nordic countries , 2004, International journal of cancer.

[49]  W. Schulz,et al.  Hypomethylation of L1 LINE sequences prevailing in human urothelial carcinoma. , 1996, Cancer research.